TrialStem cells translational medicine2024

A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke.

Daniel T Laskowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.